Literature DB >> 27896579

Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review.

Jeremy Y C Teoh1,2, Peter K F Chiu3, Chi-Hang Yee3, Hon-Ming Wong3, Chi-Kwok Chan3, Eddie S Y Chan3,4, Simon S M Hou3, Chi-Fai Ng3,4.   

Abstract

INTRODUCTION: We systemically reviewed the current evidence on prostatic artery embolization (PAE) in treating men with benign prostatic hyperplasia.
METHODS: A systemic literature search was conducted in PubMed, EMBASE and Web of Science on 1 May 2016 without time constraints. Outcomes of interest included the changes in the International Prostate Symptom Score (IPSS), quality-of-life (QOL) score, peak urinary flow (Qmax), post-void residual urine (PVR), International Index of Erectile Function (IIEF) score, prostate volume (PV) and prostate-specific antigen (PSA) level.
RESULTS: A total of 987 records were identified through database searching. After removing duplicates, screening and reviewing full-length texts, a total of five records remained, with two randomized controlled trials and three non-randomized cohort studies. Transurethral resection of prostate resulted in better IPSS than PAE. Open prostatectomy had better IPSS, QOL score, Qmax and PVR, but worse IIEF score than PAE at 1 year. Unilateral PAE had higher rate of poor clinical outcome than bilateral PAE, but the difference became statistically insignificant after adjusting for age; IPSS, QOL score, Qmax, PVR, IIEF score, PV and PSA did not differ between the two groups. PAE with 100 μm PVA particles resulted in greater reduction in PSA level, but worse IIEF score than PAE with 200 μm PVA particles; IPSS, QOL score, Qmax, PVR, PV and poor clinical outcome did not differ between the two groups.
CONCLUSION: Evidence on different aspects of PAE was limited. Further studies are warranted to investigate the role of PAE as compared to other forms of medical and surgical treatment.

Entities:  

Keywords:  Embolisation; Embolization; Prostate; Prostatic disease

Mesh:

Year:  2016        PMID: 27896579     DOI: 10.1007/s11255-016-1461-2

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Self management for men with lower urinary tract symptoms: randomised controlled trial.

Authors:  Christian T Brown; Tet Yap; David A Cromwell; Lorna Rixon; Liz Steed; Kathleen Mulligan; Anthony Mundy; Stanton P Newman; Jan van der Meulen; Mark Emberton
Journal:  BMJ       Date:  2006-11-21

Review 2.  The National Prostatectomy Audit.

Authors:  D E Neal
Journal:  Br J Urol       Date:  1997-04

3.  A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.

Authors:  B Djavan; M Marberger
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

4.  Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement.

Authors:  Tiago Bilhim; João Pisco; Hugo Rio Tinto; Lúcia Fernandes; Luís Campos Pinheiro; Marisa Duarte; José A Pereira; António G Oliveira; João O'Neill
Journal:  Cardiovasc Intervent Radiol       Date:  2012-12-12       Impact factor: 2.740

5.  Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions.

Authors:  Vincenzo Serretta; Giuseppe Morgia; Luigi Fondacaro; Gaetano Curto; Antonio Lo bianco; Domenico Pirritano; Darwin Melloni; Fausto Orestano; Mario Motta; Michele Pavone-Macaluso
Journal:  Urology       Date:  2002-10       Impact factor: 2.649

6.  High prevalence of benign prostatic hypertrophy in the community.

Authors:  W M Garraway; G N Collins; R J Lee
Journal:  Lancet       Date:  1991-08-24       Impact factor: 79.321

7.  Prostatic Arterial Embolization vs Open Prostatectomy: A 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities.

Authors:  Giorgio Ivan Russo; Dmitry Kurbatov; Salvatore Sansalone; Alexander Lepetukhin; Sergey Dubsky; Ivan Sitkin; Costanza Salamone; Livio Fiorino; Roman Rozhivanov; Sebastiano Cimino; Giuseppe Morgia
Journal:  Urology       Date:  2015-07-18       Impact factor: 2.649

8.  Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study.

Authors:  Tiago Bilhim; João Pisco; Luís Campos Pinheiro; Hugo Rio Tinto; Lúcia Fernandes; José A Pereira; Marisa Duarte; António G Oliveira
Journal:  J Vasc Interv Radiol       Date:  2013-08-03       Impact factor: 3.464

9.  Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial.

Authors:  Yuan-an Gao; Yan Huang; Rui Zhang; Yu-dong Yang; Qing Zhang; Min Hou; Yi Wang
Journal:  Radiology       Date:  2013-11-13       Impact factor: 11.105

10.  Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.

Authors:  Francisco C Carnevale; Alexandre Iscaife; Eduardo M Yoshinaga; Airton Mota Moreira; Alberto A Antunes; Miguel Srougi
Journal:  Cardiovasc Intervent Radiol       Date:  2015-10-27       Impact factor: 2.740

View more
  3 in total

1.  Long-Term Efficacy and Recurrence Prediction of Prostatic Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Authors:  Zhong-Wei Xu; Chun-Gao Zhou; Wei Tian; Hai-Bin Shi; Sheng Liu
Journal:  Cardiovasc Intervent Radiol       Date:  2022-09-21       Impact factor: 2.797

2.  Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients.

Authors:  Kun Wang; Ming Chen; Yiqing Liu; Weiren Xiao; Yonghong Qian; Xu Liu
Journal:  Front Surg       Date:  2022-05-17

3.  Prostatic Artery Embolization for Benign Prostatic Hyperplasia: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.